StonvexLoading…
StonvexStonvexStonvexCore line items from CNA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.58B | $1.61B | $1.62B | $1.57B |
Operating Income | $1.62B | $1.21B | $1.52B | $814.00M |
Net Income | $1.28B | $959.00M | $1.21B | $682.00M |
EPS (Diluted) | $4.69 | $3.52 | $4.43 | $2.51 |
Total Assets | $69.44B | $66.49B | $64.71B | $61.00B |
Total Liabilities | $57.82B | $55.98B | $54.82B | $52.45B |
Cash & Equivalents | $425.00M | $472.00M | $345.00M | $475.00M |
Free Cash Flow OCF − CapEx | $2.40B | $2.48B | $2.19B | $2.45B |
Shares Outstanding | 270.67M | 270.84M | 270.88M | 270.90M |